JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i5.7342ArticleComparative Analysis of Budesonide Treatments on Blood Gas and Inflammation in Chronic Obstructive Pulmonary Disease Remissionhttps://artdesignp.com/journal/JCNR/8/5/10.26689/jcnr.v8i5.7342LiuWei2024852024-06-24Objective: To investigate the effects of budesonide on blood gas and inflammation indexes in patients with chronic obstructive pulmonary disease (COPD) during remission. Methods: Fifty-one patients with COPD in remission, admitted to Zhongshan Hospital of Dalian University from July 2021 to December 2022, were selected and divided into two groups based on a randomized numerical table method. The control group (25 cases) received budesonide formoterol treatment, while the observation group (26 cases) received budesonide geforce treatment. Various indexes, including clinical efficacy, blood gas indexes, inflammation indexes, St. George’s Respiratory Questionnaire (SGRQ) scores, Chronic Obstructive Pulmonary Disease Assessment Test (CAT) scores, and 6-minute Walking Distance Test (6MWD) results, were compared between the two groups. Results: After 21 days of treatment, the total clinical effectiveness rate of the observation group was higher than that of the control group, with a statistically significant difference (P < 0.05). Post-treatment, the PaO2 level and pH value in both groups were higher, and the PaCO2 level was lower compared to pre-treatment levels. The observation group showed better improvements in these indicators than the control group, with statistically significant differences (P < 0.05). SGRQ and CAT scores for both groups were lower post-treatment, with the observation group scoring lower than the control group. Additionally, the 6MWD results were farther for both groups post-treatment, with the observation group achieving greater distances than the control group, with statistically significant differences (P < 0.05). Conclusion: Budesonide can effectively improve blood gas indexes in patients with COPD in remission, alleviate related clinical symptoms, reduce inflammatory responses, and promote patient recovery. The treatment efficacy is significant.

Messous S, Elargoubi A, Pillet S, et al., 2021, Bacterial and Viral Infection in Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Implication for Antimicrobial Management and Clinical Outcome. COPD, 18(1): 53–61. https://doi.org/10.1080/15412555.2020.1854210

Gao F, Wang Q, Li R, et al., 2021, Effectiveness of Inhaled Glucocorticoid-Containing Triple Therapy on the Frequency of Acute Exacerbations in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease with Different Blood Eosinophil Percentages. Chinese Journal of Respiratory and Critical Care, 20(10): 685–689.

Luo B, Qin N, Liu Y, 2019, Effects of Fluticasone Propionate Nebulized Inhaler Combined with Yifei Huoxue Granules on Changes in Serum TGF-beta1 and sICAM-1 Levels and Lung Function in Patients with Stable COPD. Guangdong Medical Journal, 40(4): 559–562.

Chinese Medical Association, Chinese Medical Association Publishing House, Chinese Medical Association General Practice Branch, et al., 2018, Guidelines for Primary Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2018). Chinese Journal of General Practitioners, 17(11): 856–870.

Yan L, Peng Y, He W, et al. Efficacy of Saint George’s Respiratory Questionnaire in Treatment of Pneumoconiosis with Acetylcysteine and Tetrandrine. Chinese Journal of Industrial Medicine, 35(6): 505–508.

Meng X, He Y, Mao R, et al., 2022, Application of St. George’s Respiratory Questionnaire, CAT and mMRC Score in Chronic Obstructive Pulmonary Disease. Fudan Journal (Medical Journal), 49(6): 862–868 + 876.

Yang S, Bu X, Huang Z, et al., 2022, Effect of Wuqinxi on 6-Minute Walk Test Distance in Patients with Chronic Heart Failure. Clinical Journal of Chinese Medicine, 14(33): 38–40.

Bian M, Bu L, 2022, A Controlled Study on the Effects of Budesonide Formoterol Inhaler and Budesonide Inhaler on Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in Remission. Practical Medicine and Clinics, 25(1): 42–45.

Hu Y, He S, 2022, Analysis of the Efficacy and Safety of Budesonide Inhalation Aerosol in Patients with Chronic Obstructive Pulmonary Disease. Medical Theory and Practice, 35(2): 234–236.

Chen Q, Li X, 2023, Efficacy of Budesonide Inhalation Aerosol in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. China Modern Physician, 61(9): 65–68 + 88.

Fan X, 2021, Analysis of the Efficacy of Budesonide Inhalation Aerosol on Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. China Drugs and Clinics, 21(24): 3994–3997.